Sulfateq BV | Empowering health
  • Home
  • About us
  • Programs & Pipeline
  • Scientific data
  • Partnering
    • Investors
  • Newsroom
  • Contact us
Select Page

SULFATEQ and GEN sign definitive collaboration agreement to develop a therapy for Alzheimer’s Disease and additional Neurodegenerative Diseases

by Vincent Schermer | Aug 24, 2021 | News

Groningen, The Netherlands & Ankara, Turkey – Sulfateq BV, an early stage biotech company developing a group of small molecules that maintain mitochondrial health, and GEN İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. (GEN), a publicly traded company...
  • RSS
Sulfateq BV - Copyright 2021